Pharmaceuticals

Excelsus invites pharma companies to explore for free the possibilities of synchrotron X-ray powder diffraction

The second annual Spring Pharmaceutical Synchrotron X-Ray Powder Diffraction (SPS-XRPD-2) Workshop, organized together with the 16th Pharmaceutical Powder...

More details More details

A perfect site for biotech and pharma companies!

Drug discovery has come a long way from crude extracts to pure chemicals, from guess work to a structural and targeted approach to finding new and better...

More details

Pharmaceutical formulations: Excelsus quantifies amorphous drug forms

Using state-of-the-art synchrotron X-ray powder diffraction at the Paul Scherrer Institute (PSI) and the pair distribution function (PDF) technique, Excelsus...

More details

Electron diffraction opens new possibilities for structure-based drug discovery

Modern pharmaceutical development is tailored to the chemical and physical characteristics of active organic compounds. The reason why the atomic structure...

More details

The value of the absolute structure

The exact knowledge and understanding of a molecule’s structure underpin all the substantial progress in chemical, agrarian and pharmaceutical research....

More details

Crystallization at its best

The success of many R&D projects in the pharmaceutical, chemical or agro industries depends on the exact and complete knowledge of a sample. To deliver...

More details

Technology as a Tool for Drug Discovery Innovation

Interview with Dr. Oliver Nayler, Head of Cardiovascular & Fibrosis Biology at Actelion Pharmaceutical Ltd. Actelion Pharmaceutical Ltd. is the leading...

More details

Dr. Fabia Gozzo: "Our customers come from all over the world."

Interview with Dr. Fabia Gozzo, Founder and CEO of Excelsus Structural Solutions (Swiss) AG Excelsus Structural Solutions (Swiss) AG, Villigen, a spin-off...

More details
Subscribe to Pharmaceuticals